Literature DB >> 25955808

Radiological features of infantile glioblastoma and desmoplastic infantile tumors: British Columbia's Children's Hospital experience.

Ahmad Bader1, Manraj Heran2, Christopher Dunham3, Paul Steinbok1,4.   

Abstract

OBJECT Two of the more common infantile brain tumors, glioblastoma multiforme (GBM) and desmoplastic infantile tumors (DITs), can be difficult to distinguish on MRI. Both tumors occur in the supratentorial compartment and both have solid and cystic components. Differentiating between the 2 on MRI studies could assist the surgeon in discussions with family and child management. The authors report on their institutional experience with both tumors, focusing on radio-graphic features, especially the diffusion studies, which might be useful in distinguishing between infantile GBM and DIT. METHODS A retrospective review was undertaken of all infantile brain tumors treated at British Columbia's Children's Hospital between 1982 and 2012, and cases of GBM and DIT were recorded. Only cases that had imaging were included in the study. A literature review was completed to identify reported cases of infantile GBM and DIT. Only reports that described or included radiological studies (particularly MRI) of the tumors were included. Certain radiographic features of the tumors were reviewed, including location, size, consistency, pattern of enhancement, and features on MR diffusion studies. RESULTS Of 70 cases of infantile brain tumors, 2 GBM cases and 3 DIT cases (all 3 of which were desmoplastic infantile gangliogliomas [DIGs]) met the inclusion criteria. The radiological studies obtained in all 5 cases were reviewed by a neuroradiologist. All 5 patients had supratentorial tumors with cystic-solid consistency. Diffusion MRI studies showed restricted diffusion in the 2 GBM cases, but no evidence of restricted diffusion in the DIG tumors. The GBM tumors were heterogeneously enhancing, and the DIG tumors showed avid and homogeneous enhancement. The literature review revealed 29 cases of infantile GBM and 32 cases of DIG/DIT that met the inclusion criteria. The tumors were large in both groups. The tumors were cystic-solid in consistency in 10 of 30 (33%) of GBM cases and 28 of 32 (87.5%) of DIT cases. The contrast enhancement was heterogeneous in 9 of 30 (30%) GBM cases, and it was homogeneous and avid in 27 of 32 (84%) of DIT cases. Diffusion studies were recorded in 2 published infantile GBM cases, and in both of them diffusion was restricted. The authors only found 1 report that discussed DIG tumor features on MR diffusion studies, but the interpretation was difficult and unclear. CONCLUSIONS Magnetic resonance imaging, especially diffusion-weighted imaging, may be a useful aid in distinguishing between infantile GBM and DIT tumors, with infantile GBM demonstrating restricted diffusion.

Entities:  

Keywords:  ADC = apparent diffusion coefficient; BCCH = British Columbia’s Children’s Hospital; DIG = desmoplastic infantile ganglioglioma; DIT = desmoplastic infantile tumor; DWI = diffusion-weighted imaging; GBM = glioblastoma multiforme; GFAP = glial fibrillary acidic protein; PNET = primitive neuroectodermal tumor; brain magnetic resonance imaging; congenital brain tumors; desmoplastic infantile astrocytoma; desmoplastic infantile ganglioglioma; diffusion; infantile glioblastoma; oncology

Mesh:

Year:  2015        PMID: 25955808     DOI: 10.3171/2014.10.PEDS13634

Source DB:  PubMed          Journal:  J Neurosurg Pediatr        ISSN: 1933-0707            Impact factor:   2.375


  10 in total

1.  Novel suprasellar location of desmoplastic infantile astrocytoma and ganglioglioma: a single institution's experience.

Authors:  Ryan M Naylor; Anton Wohl; Aditya Raghunathan; Laurence J Eckel; Gesina F Keating; David J Daniels
Journal:  J Neurosurg Pediatr       Date:  2018-07-06       Impact factor: 2.375

2.  Atypical imaging in a desmoplastic non-infantile astrocytoma.

Authors:  Abhishek Gupta; Madhivanan Karthigeyan; Kirti Gupta; Pravin Salunke
Journal:  Childs Nerv Syst       Date:  2016-10-20       Impact factor: 1.475

Review 3.  Supratentorial tumors typical of the infantile age: desmoplastic infantile ganglioglioma (DIG) and astrocytoma (DIA). A review.

Authors:  F Bianchi; G Tamburrini; L Massimi; M Caldarelli
Journal:  Childs Nerv Syst       Date:  2016-09-20       Impact factor: 1.475

4.  Mixed Solid and Cystic Mass in an Infant.

Authors:  J C Benson; D Summerfield; J B Guerin; D Kun Kim; L Eckel; D J Daniels; P Morris
Journal:  AJNR Am J Neuroradiol       Date:  2019-10-03       Impact factor: 3.825

Review 5.  Radiohistogenomics of pediatric low-grade neuroepithelial tumors.

Authors:  Asim K Bag; Jason Chiang; Zoltan Patay
Journal:  Neuroradiology       Date:  2021-03-29       Impact factor: 2.804

Review 6.  Perinatal (fetal and neonatal) astrocytoma: a review.

Authors:  Hart Isaacs
Journal:  Childs Nerv Syst       Date:  2016-08-27       Impact factor: 1.475

7.  Progressive Disordered Movements in an Infant Leads to Rare Diagnosis.

Authors:  Sarah Pasquale; Aaron Dam; Christopher Kelly; Romaine Schubert; Laura Melville
Journal:  Clin Pract Cases Emerg Med       Date:  2017-01-24

8.  Establishment and Characterization of Brain Cancer Primary Cell Cultures From Patients to Enable Phenotypic Screening for New Drugs.

Authors:  Michelle dePadua; Preethi Kulothungan; Rahul Lath; Ravikanti Prasad; Kranthi Madamchetty; Shravya Atmakuri; Sravanthi Ragamouni; Mukesh Gandhari; Lakshmipathi Khandrika; Jugnu Jain
Journal:  Front Pharmacol       Date:  2022-03-17       Impact factor: 5.810

9.  A Case Report of a Rare Pediatric Brain Tumor: Congenital Glioblastoma.

Authors:  Antonio G Junior; Nina M P Abreu; Marcus Vinícius B Leal; Hilanne L A de Aquino; João Paulo C Rodrigues; Caio B Malveira; Yael P Silva; Pablo P A Coimbra
Journal:  Cureus       Date:  2022-03-16

10.  Inflammatory myofibroblastic lung tumor transforming into intracranial desmoplastic noninfantile ganglioglioma: A case report and literature review.

Authors:  Fu Wei; Seidu A Richard; Junya Tan; Zhigang Lan; Yan Ju
Journal:  Medicine (Baltimore)       Date:  2018-10       Impact factor: 1.817

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.